Tenaya Therapeutics (TNYA) FCF Margin (2026)
Tenaya Therapeutics (TNYA) posted quarterly FCF Margin of 8343.56% for Q1 2026.
Tenaya Therapeutics (TNYA) FCF Margin (2026) Analysis & Trends
Tenaya Therapeutics' FCF Margin history runs 1 years deep, the most recent figure standing at 8343.56% for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 22.62% |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 41.07% |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | -22.35% |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 70.82% |
| 10 | Tenaya Therapeutics | 155.02 Mn | 155.02 Mn | - | -323.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -323.33% |
| Mar 31, 2026 | -8,343.56% |